<DOC>
	<DOCNO>NCT01136707</DOCNO>
	<brief_summary>The purpose study examine relationship load dose adherence Orencia .</brief_summary>
	<brief_title>Predictors Adherence Orencia</brief_title>
	<detailed_description />
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Patients identify base presence first infusion claim study period Orencia At least 1 medical facility claim rheumatoid arthritis time 6 month prior index date Patients require continuously enrol minimum preindex followup period detail Patients minimum 3 infusion claim Orencia Only patient include whose first 3 infusion claim occur within 84 day Patients less 18 year age index date . One diagnose regional enteritis ( include Crohn 's disease ) , ulcerative colitis , anal intestinal fistula , ankylose spondylitis inflammatory spondylopathy , psoriatic arthropathy , psoriasis time 6month preindex period Patients switch biologics within first three infusion claim Restarts , define patient go back Orencia gap 42 day Patients biologics time Orencia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>